1016 related articles for article (PubMed ID: 11422104)
41. Dose-dependent changes in body composition during growth hormone (GH) treatment in Japanese patients with adult GH deficiency: a randomized, placebo-controlled trial.
Chihara K; Fujieda K; Shimatsu A; Miki T; Tachibana K
Growth Horm IGF Res; 2010 Jun; 20(3):205-11. PubMed ID: 20176498
[TBL] [Abstract][Full Text] [Related]
42. Serum insulin-like growth factor I (IGF-I), IGF-binding protein-1 and -3, and the acid-labile subunit as serum markers of body composition during growth hormone (GH) therapy in adults with GH deficiency.
Thorén M; Hilding A; Baxter RC; Degerblad M; Wivall-Helleryd IL; Hall K
J Clin Endocrinol Metab; 1997 Jan; 82(1):223-8. PubMed ID: 8989263
[TBL] [Abstract][Full Text] [Related]
43. The effects of two doses of replacement growth hormone on the biochemical, body composition and psychological profiles of growth hormone-deficient adults.
Carroll PV; Littlewood R; Weissberger AJ; Bogalho P; McGauley G; Sönksen PH; Russell-Jones DL
Eur J Endocrinol; 1997 Aug; 137(2):146-53. PubMed ID: 9272102
[TBL] [Abstract][Full Text] [Related]
44. Dose-, IGF-I- and sex-dependent changes in lipid profile and body composition during GH replacement therapy in adult onset GH deficiency.
Abrahamsen B; Nielsen TL; Hangaard J; Gregersen G; Vahl N; Korsholm L; Hansen TB; Andersen M; Hagen C
Eur J Endocrinol; 2004 May; 150(5):671-9. PubMed ID: 15132723
[TBL] [Abstract][Full Text] [Related]
45. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
Hokken-Koelega AC; van Pareren Y; Sas T; Arends N
Horm Res; 2003; 60 Suppl 3():113-4. PubMed ID: 14671407
[TBL] [Abstract][Full Text] [Related]
46. Three weekly injections (TWI) of low-dose growth hormone (GH) restore low normal circulating IGF-I concentrations and reverse cardiac abnormalities associated with adult onset GH deficiency (GHD).
Pincelli AI; Bragato R; Scacchi M; Branzi G; Osculati G; Viarengo R; Leonetti G; Cavagnini F
J Endocrinol Invest; 2003 May; 26(5):420-8. PubMed ID: 12906369
[TBL] [Abstract][Full Text] [Related]
47. The association between growth response to growth hormone and baseline body composition of children with growth hormone deficiency.
Esen I; Demirel F; Tepe D; Kara O; Koc N
Growth Horm IGF Res; 2013 Oct; 23(5):196-9. PubMed ID: 23890535
[TBL] [Abstract][Full Text] [Related]
48. [Growth hormone deficiency in adults: effects of replacement therapy on body composition and health-related quality of life].
Mesa J; Gómez JM; Hernández C; Picó A; Ulied A;
Med Clin (Barc); 2003 Jan; 120(2):41-6. PubMed ID: 12570912
[TBL] [Abstract][Full Text] [Related]
49. [The beneficial effects of growth hormone replacement therapy on elderly men].
Kozakowski J; Adamkiewicz M; Krassowski J; Zgliczyński S
Pol Merkur Lekarski; 1999 Mar; 6(33):131-4. PubMed ID: 10365596
[TBL] [Abstract][Full Text] [Related]
50. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
Drake WM; Rodríguez-Arnao J; Weaver JU; James IT; Coyte D; Spector TD; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
[TBL] [Abstract][Full Text] [Related]
51. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
Cohen P; Rogol AD; Howard CP; Bright GM; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2007 Jul; 92(7):2480-6. PubMed ID: 17356043
[TBL] [Abstract][Full Text] [Related]
52. Low-dose growth hormone replacement lowers plasma leptin and fat stores without affecting body mass index in adults with growth hormone deficiency.
Florkowski CM; Collier GR; Zimmet PZ; Livesey JH; Espiner EA; Donald RA
Clin Endocrinol (Oxf); 1996 Dec; 45(6):769-73. PubMed ID: 9039344
[TBL] [Abstract][Full Text] [Related]
53. Changes in body composition and leptin levels during growth hormone (GH) treatment in short children with various GH secretory capacities.
Matsuoka H; Fors H; Bosaeus I; Rosberg S; Albertsson-Wikland K; Bjarnason R
Eur J Endocrinol; 1999 Jan; 140(1):35-42. PubMed ID: 10037249
[TBL] [Abstract][Full Text] [Related]
54. Discontinuing long-term GH replacement therapy--a randomized, placebo-controlled crossover trial in adult GH deficiency.
Filipsson Nyström H; Barbosa EJ; Nilsson AG; Norrman LL; Ragnarsson O; Johannsson G
J Clin Endocrinol Metab; 2012 Sep; 97(9):3185-95. PubMed ID: 22791760
[TBL] [Abstract][Full Text] [Related]
55. Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency.
Biller BM; Sesmilo G; Baum HB; Hayden D; Schoenfeld D; Klibanski A
J Clin Endocrinol Metab; 2000 Mar; 85(3):970-6. PubMed ID: 10720025
[TBL] [Abstract][Full Text] [Related]
56. The effects of treatment and the individual responsiveness to growth hormone (GH) replacement therapy in 665 GH-deficient adults. KIMS Study Group and the KIMS International Board.
Bengtsson BA; Abs R; Bennmarker H; Monson JP; Feldt-Rasmussen U; Hernberg-Stahl E; Westberg B; Wilton P; Wüster C
J Clin Endocrinol Metab; 1999 Nov; 84(11):3929-35. PubMed ID: 10566630
[TBL] [Abstract][Full Text] [Related]
57. Influence of growth hormone on whole body and regional soft tissue composition in adult patients on hemodialysis. A double-blind, randomized, placebo-controlled study.
Hansen TB; Gram J; Jensen PB; Kristiansen JH; Ekelund B; Christiansen JS; Pedersen FB
Clin Nephrol; 2000 Feb; 53(2):99-107. PubMed ID: 10711411
[TBL] [Abstract][Full Text] [Related]
58. Low-dose GH improves exercise capacity in adults with GH deficiency: effects of a 22-month placebo-controlled, crossover trial.
Bollerslev J; Hallén J; Fougner KJ; Jørgensen AP; Kristo C; Fagertun H; Gudmundsen O; Burman P; Schreiner T
Eur J Endocrinol; 2005 Sep; 153(3):379-87. PubMed ID: 16131600
[TBL] [Abstract][Full Text] [Related]
59. Whole body and regional soft tissue changes in growth hormone deficient adults after one year of growth hormone treatment: a double-blind, randomized, placebo-controlled study.
Hansen TB; Vahl N; Jørgensen JO; Christiansen JS; Hagen C
Clin Endocrinol (Oxf); 1995 Dec; 43(6):689-96. PubMed ID: 8736270
[TBL] [Abstract][Full Text] [Related]
60. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance.
Hana V; Silha JV; Justova V; Lacinova Z; Stepan JJ; Murphy LJ
Clin Endocrinol (Oxf); 2004 Apr; 60(4):442-50. PubMed ID: 15049958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
